Where
Medicine Begins

Help Improve Lives.
Enjoy the Experience.

Get Early Access to New Medicines

Clinical studies offer more care options for patients suffering from common, unique, and rare health conditions.

Help Move Science Forward

Clinical studies offer a way for almost anyone — regardless of their background — to help improve human health and wellbeing.

Receive Compensation if You Qualify

Most Meridian studies offer payment for time and travel. We'll let you know what to expect during your first phone call with Meridian.

Give Hope to People Worldwide

Clinical trials offer hope for many people and an opportunity to help researchers find better treatments for others in the future.

Do I need insurance to join a study?

Will I be paid for my time?

What are the potential benefits or risks?

How long does a study last?

Will I get study-related care from a local doctor?

What studies are open now?

Senior_Female_Young_Male

Talk to a Meridian Enrollment Specialist...

Midwest

(402) 934-7563

Mon.-Fri., 8 a.m.-7 p.m.; Sat. 9 a.m.-Noon (CT)

South and East Coast

(912) 623-2240

Mon.-Th., 8 a.m.-7 p.m.; Fri., 8 a.m.-5 p.m. (ET)

k+
Subjects Enrolled
+
Studies Conducted
%
Enrollment for Vaccine Trials
Years in Research

Clients and Partners

Meridian provides Phase I-IV research services for Sponsors and CROs developing drugs, medical devices, and diagnostics across numerous therapeutic areas.

Amgen, Abbvie, Abbott, AstraZeneca, Bayer, Bristol-Meyers Squibb, Dermira, Genentech, GlaxcoSmithKline, Johnson and Johnson, Medicago, Merck, Moderna, Novartis, NovoNordisk, Pfizer, Regeneron. Sanofi Pasteur. Seqirus, Takeda

News

Recap: Meridian Good Deeds Day 2018

January 3, 2019

For 2018’s Good Deeds Day, employees at each Meridian site were given a cash stipend and a simple instruction: Go into your community and make a difference. We were blown away by the thoughtfulness with … Read more

Positive Results Announced for Phase III Clinical Trial of Evofem Hormone-Free Birth Control Product; Meridian Site Involved

December 18, 2018

Evofem Biosciences, Inc. (NASDAQ: EVFM) (“Evofem” or the “Company”) today announced that its Phase 3 clinical trial of Amphora® for the prevention of pregnancy, AMPOWER, successfully met its primary endpoint. AMPOWER assessed the efficacy, safety … Read more

Michael Hemphill, MD, Receives Health Professional Impact Award from the National Multiple Sclerosis Society

December 10, 2018

Savannah, Ga., December 10, 2018 — Michael Hemphill, MD, has received the 2018 Health Professional Impact Award from the National Multiple Sclerosis Society (NMSS). He is a principal investigator at Meridian Clinical Research, and has … Read more

Meridian to Celebrate Annual ‘Good Deeds Day’ by Giving Back to Several Communities

December 3, 2018

Omaha, Neb., December 3, 2018 — Throughout the week of December 3-7, each Meridian Clinical Research location will celebrate a Good Deeds Day. This year’s activities will be held across all of Meridian’s 15 U.S. … Read more